A lot of the information on this site was taken from a *large* FAQ file put together by a group of HCV sufferers. To get the entire FAQ, send email through our online form

You can also get the FAQs on these websites:
http://www.flash.net/~twb/BACafe (You'll find it in the "Peppermint Room" there)
http://members.bellatlantic.net/~clotho

© 1996-2006

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....

Improves Outcome for Hep C Genotype 4
Currently approved for treating contagious diarrhea in children, nitazoxanide has been found to make pegylated interferon-based treatment for Hepatitis C genotype 4 more effective. Prompting new trials in the U.S. and Europe, this drug is now being evaluated for Hepatitis...